Filing
Spy
Filing
Spy
Home
About
KRTX — Karuna Therapeutics Inc - FilingSpy
KRTX
Karuna Therapeutics Inc
Biopharmaceutical company focused on neurological and psychiatric treatments
CUSIP: 48576A100
Healthcare
US
3 holders
Ownership
Activity
2022 Q4
5 of 14 quarters
Total Value
$264.57M
Total Shares
1.35M
Net Share Change
+144.3K
Activity
1 buying
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$232.60M
1.18M
1.2%
ADD
+169.6K
(+16.7%)
Viking Global Investors
$232.60M
1.18M shares
ADD
+169.6K
(+16.7%)
Miller Value Partners
$28.49M
145.0K
1.8%
TRIM
-25.4K
(-14.9%)
Miller Value Partners
$28.49M
145.0K shares
TRIM
-25.4K
(-14.9%)
Patient Capital Management
$3.48M
17.7K
1.7%
Unchanged
Patient Capital Management
$3.48M
17.7K shares
Unchanged